Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature.

Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature.

[Anonymous].  2008.  Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature.. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. 3(4):286-95.

Event-free survival in adults with heart failure who engage in self-care management.

Zinc deficiency induces vascular pro-inflammatory parameters associated with NF-kappaB and PPAR signaling.

Theory-based low-sodium diet education for heart failure patients.

PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities.

PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities.

[Anonymous].  2009.  PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 23(5):1596-606.

Depressive symptoms affect the relationship of N-terminal pro B-type natriuretic peptide to cardiac event-free survival in patients with heart failure.

Depressive symptoms affect the relationship of N-terminal pro B-type natriuretic peptide to cardiac event-free survival in patients with heart failure.

[Anonymous].  2010.  Depressive symptoms affect the relationship of N-terminal pro B-type natriuretic peptide to cardiac event-free survival in patients with heart failure.. Journal of cardiac failure. 16(7):572-8.

Flavonoids protect against intercellular adhesion molecule-1 induction by benzo a pyrene.

Understanding the negative effects of depressive symptoms in patients with ESRD receiving hemodialysis.

Symptom variability, not severity, predicts rehospitalization and mortality in patients with heart failure.

Symptom variability, not severity, predicts rehospitalization and mortality in patients with heart failure.

[Anonymous].  2011.  Symptom variability, not severity, predicts rehospitalization and mortality in patients with heart failure.. European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology. 10(2):124-9.

Predictors of depressive symptoms in caregivers of patients with heart failure.